Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 51% ± 12% | |
| lung | 17 studies | 35% ± 12% | |
| intestine | 13 studies | 29% ± 14% | |
| kidney | 9 studies | 35% ± 14% | |
| liver | 7 studies | 33% ± 15% | |
| brain | 6 studies | 31% ± 6% | |
| bone marrow | 4 studies | 31% ± 18% | |
| uterus | 4 studies | 37% ± 12% | |
| lymph node | 4 studies | 48% ± 11% | |
| breast | 4 studies | 34% ± 10% | |
| eye | 3 studies | 18% ± 0% | |
| heart | 3 studies | 18% ± 3% | |
| adrenal gland | 3 studies | 31% ± 14% | |
| placenta | 3 studies | 31% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 9552.23 | 966 / 966 | 100% | 147.63 | 527 / 527 |
| kidney | 100% | 11221.42 | 89 / 89 | 100% | 168.25 | 901 / 901 |
| liver | 100% | 11317.08 | 226 / 226 | 100% | 176.47 | 406 / 406 |
| ovary | 100% | 3960.35 | 180 / 180 | 100% | 132.66 | 430 / 430 |
| skin | 100% | 6133.80 | 1809 / 1809 | 100% | 129.13 | 472 / 472 |
| stomach | 100% | 6096.48 | 359 / 359 | 100% | 131.50 | 286 / 286 |
| thymus | 100% | 9434.96 | 653 / 653 | 100% | 104.82 | 605 / 605 |
| uterus | 100% | 5440.48 | 170 / 170 | 100% | 99.96 | 459 / 459 |
| lung | 100% | 7033.85 | 578 / 578 | 100% | 80.78 | 1152 / 1155 |
| pancreas | 100% | 4196.12 | 327 / 328 | 100% | 117.41 | 178 / 178 |
| bladder | 100% | 5944.38 | 21 / 21 | 100% | 125.30 | 502 / 504 |
| breast | 100% | 8680.51 | 459 / 459 | 99% | 109.85 | 1112 / 1118 |
| prostate | 100% | 6452.67 | 245 / 245 | 99% | 73.50 | 497 / 502 |
| esophagus | 100% | 5707.15 | 1445 / 1445 | 99% | 68.19 | 181 / 183 |
| adrenal gland | 100% | 8924.40 | 258 / 258 | 98% | 81.89 | 226 / 230 |
| brain | 90% | 2232.72 | 2376 / 2642 | 100% | 74.88 | 705 / 705 |
| adipose | 100% | 7749.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 100.71 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 129.14 | 29 / 29 |
| spleen | 100% | 13138.49 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 76.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 64.12 | 1 / 1 |
| blood vessel | 100% | 4743.21 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 8712.67 | 926 / 929 | 0% | 0 | 0 / 0 |
| muscle | 100% | 4483.97 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 7869.28 | 855 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0098869 | Biological process | cellular oxidant detoxification |
| GO_0030855 | Biological process | epithelial cell differentiation |
| GO_0006749 | Biological process | glutathione metabolic process |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005782 | Cellular component | peroxisomal matrix |
| GO_0016020 | Cellular component | membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0004602 | Molecular function | glutathione peroxidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004364 | Molecular function | glutathione transferase activity |
| Gene name | GSTK1 |
| Protein name | Glutathione S-transferase kappa (EC 2.5.1.18) Glutathione S-transferase kappa 1 GSTK1 protein Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13) |
| Synonyms | LOC51064 HDCMD47P tcag7.883 hCG_20682 |
| Description | FUNCTION: Glutathione S-transferase that catalyzes the conjugation of glutathione to exogenous and endogenous compounds . Significant glutathione conjugating activity is found only with the model substrate, 1-chloro-2,4-dinitrobenzene (CDNB) . . |
| Accessions | C9JNT3 ENST00000443571.6 [Q9Y2Q3-4] ENST00000436038.5 ENST00000479303.1 [Q9Y2Q3-2] ENST00000358406.10 [Q9Y2Q3-1] Q6FII1 E9PFN5 ENST00000442394.5 Q2NLC8 ENST00000409500.7 [Q9Y2Q3-3] Q9Y2Q3 |